Innovative therapeutics

Investors

NASDAQBMRN
FormDescriptionDateFormat
424B5Form of prospectus disclosing information facts events covered in both forms 424B2 424B3Aug 9, 2017Open Form of prospectus disclosing information facts events covered in both forms 424B2 424B3 in HTML.Open Form of prospectus disclosing information facts events covered in both forms 424B2 424B3 in DOC file.Open Form of prospectus disclosing information facts events covered in both forms 424B2 424B3 in PDF file.Open Form of prospectus disclosing information facts events covered in both forms 424B2 424B3 in XLS file.
424B5Form of prospectus disclosing information facts events covered in both forms 424B2 424B3Aug 7, 2017Open Form of prospectus disclosing information facts events covered in both forms 424B2 424B3 in HTML.Open Form of prospectus disclosing information facts events covered in both forms 424B2 424B3 in DOC file.Open Form of prospectus disclosing information facts events covered in both forms 424B2 424B3 in PDF file.Open Form of prospectus disclosing information facts events covered in both forms 424B2 424B3 in XLS file.
S-8Securities offered to employees pursuant to employee benefit plansJun 13, 2017Open Securities offered to employees pursuant to employee benefit plans in HTML.Open Securities offered to employees pursuant to employee benefit plans in DOC file.Open Securities offered to employees pursuant to employee benefit plans in PDF file.Open Securities offered to employees pursuant to employee benefit plans in XLS file.
S-8 POSPost-effective amendment to an S-8 filingJun 13, 2017Open Post-effective amendment to an S-8 filing in HTML.Open Post-effective amendment to an S-8 filing in DOC file.Open Post-effective amendment to an S-8 filing in PDF file.Open Post-effective amendment to an S-8 filing in XLS file.
S-8 POSPost-effective amendment to an S-8 filingJun 13, 2017Open Post-effective amendment to an S-8 filing in HTML.Open Post-effective amendment to an S-8 filing in DOC file.Open Post-effective amendment to an S-8 filing in PDF file.Open Post-effective amendment to an S-8 filing in XLS file.
S-8 POSPost-effective amendment to an S-8 filingJun 13, 2017Open Post-effective amendment to an S-8 filing in HTML.Open Post-effective amendment to an S-8 filing in DOC file.Open Post-effective amendment to an S-8 filing in PDF file.Open Post-effective amendment to an S-8 filing in XLS file.
S-8 POSPost-effective amendment to an S-8 filingJun 13, 2017Open Post-effective amendment to an S-8 filing in HTML.Open Post-effective amendment to an S-8 filing in DOC file.Open Post-effective amendment to an S-8 filing in PDF file.Open Post-effective amendment to an S-8 filing in XLS file.

BioMarin

Diseases

Lysosomal Storage Disorders (MPS I, MPS IVA, MPS VI, CLN2 disease) PKU, LEMS

Products

Palynziq®
Brineura®
Vimizim®
Kuvan®
Naglazyme®
Aldurazyme®
Firdapse®

Patient/Physician Support Contact Information

BioMarin RareConnections
Tel: 866.906.6100
Fax: 888.863.3361
E-mail: support@biomarin-rareconnections.com

Global Medical Information

Contact Global Medical Information